Antioxidant dietary supplement and related method
US-9517249-B2 · Dec 13, 2016 · US
US11191800B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11191800-B2 |
| Application number | US-201816149674-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 2, 2018 |
| Priority date | Oct 2, 2018 |
| Publication date | Dec 7, 2021 |
| Grant date | Dec 7, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention is directed to an aqueous extract of Eruca sativa (arugula) leaves that has antimicrobial activity on Gram-positive bacteria and mycoplasmas. The extract may be purified away from solid or insoluble components, standardized based on the weight of its non-aqueous or solid content, assayed for antimicrobial activity, and provided in an aseptic or sterile form for pharmaceutical use. It may be used to kill or inhibit the growth of microorganisms such as Gram positive bacteria, promote wound healing, or as prophylaxis against host colonization or infection by a microorganism.
Opening claim text (preview).
The invention claimed is: 1. A method for inhibiting the growth of a Gram positive bacterium, comprising: preparing an aqueous Eruca sativa extract by: grinding a sample consisting of dried leaves of a Eruca sativa plant, macerating the ground leaves of the Eruca sativa plant with an extractant consisting of water to extract the leaves of the Eruca sativa plant for a period of days at a temperature of about 25° C. to extract water-soluble components from the leaves of the Eruca sativa plant then filtering to form a first extract, concentrating the first extract under vacuum to produce the aqueous Eruca saliva extract in the form of a thick concentrated extract liquid, then dispensing an aqueous composition comprising the thick concentrated extract liquid from a dispenser in the form of a foam, contacting the Gram positive bacterium with the foam to inhibit the growth of the Gram positive bacterium, wherein the Gram positive bacterium is Cellulomonas strain B22. 2. The method of claim 1 , wherein the macerating is performed at a pH ranging from 6.0 to 6.5. 3. The method of claim 1 , wherein the foam contains at least 0.15 wt % of an Eruca sativa aqueous extract based on anhydrous weight or dry weight of the Eruca sativa extract. 4. The method of claim 1 , wherein contacting the Gram positive bacterium occurs in a skin, nail, or hair wound or injury. 5. The method of claim 1 , wherein contacting the Gram positive bacterium occurs in a wound or injury to a mucous membrane.
Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine · CPC title
Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi · CPC title
Antibacterial agents · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.